SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now

EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Clinical Study

Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?”.

Glickman D; Dalessio S; Raup-Konsavage WM; Vrana KE; Coates MD ·Inflammatory bowel diseases ·2023 ·DOI: 10.1093/ibd/izad222

Citation

View on PubMed

Evidence Strength

Limited evidence 43 / 100

Methodology 0/25

Highest-tier methodology assigned to the study.

Sample size 0/25

Sample size not recorded.

Peer review 25/25

Published in a peer-reviewed, PubMed-indexed journal.

Replication / recency 18/25

Published in the last 5 years; replication evidence pending.

How is this calculated?

Other studies in this cluster

Inflammation

[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Schmerz (Berlin, Germany) · 2016

Systematic Review n=21

Inflammation

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.

Journal of affective disorders · 2015

Inflammation

Cannabinoids and autoimmune diseases: A systematic review.

Autoimmunity reviews · 2016

Systematic Review

Inflammation

Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease.

Journal of pediatric gastroenterology and nutrition · 2017

Inflammation

Pain in Extrapyramidal Neurodegenerative Diseases.

The Clinical journal of pain · 2017

n=371

Inflammation

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.

European archives of psychiatry and clinical neuroscience · 2017

Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?”.

Citation

Other studies in this cluster

[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.

Cannabinoids and autoimmune diseases: A systematic review.

Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease.

Pain in Extrapyramidal Neurodegenerative Diseases.

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.

Contact us

Categories

Editions

Business of cannabis

Popular

Time is running out to nominate

Recent Searches

Popular Searches

Recent Searches

Popular Searches

Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?”.

Citation

Other studies in this cluster

[Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.

Cannabinoids and autoimmune diseases: A systematic review.

Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease.

Pain in Extrapyramidal Neurodegenerative Diseases.

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.

Cannabis news, every Monday morning.

Time is running out to nominate